| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1467.2B | ¥1621.0B | -9.5% |
| Operating Income | ¥63.1B | ¥88.6B | -28.8% |
| Ordinary Income | ¥60.3B | ¥79.3B | -24.0% |
| Net Income | ¥50.6B | ¥56.0B | -9.6% |
| ROE | 10.1% | 11.4% | - |
FY2026 Q3 results showed revenue of 146.7B yen (YoY -9.5%), operating income of 6.3B yen (YoY -28.8%), ordinary income of 6.0B yen (YoY -24.0%), and net income of 5.1B yen (YoY -9.8%, estimated from prior comparison). Profitability contracted across all stages with operating margin declining 117 basis points to 4.3% and gross margin narrowing 29 basis points to 14.9%. The company recorded a one-time gain of 1.1B yen from investment securities sales, which supported bottom-line results. Operating cash flow remained robust at 8.9B yen, 1.77 times net income, driven primarily by advances received increasing 8.0B yen and inventory reduction contributing 4.8B yen. Deleveraging progressed with long-term borrowings decreasing 38.4% and interest coverage maintaining a healthy 39.7 times, though working capital efficiency deteriorated with days sales outstanding and days inventory outstanding each extending to approximately 135 days.
[Profitability] ROE of 10.0% reflects net profit margin of 3.4%, total asset turnover of 0.927, and financial leverage of 3.16. Operating margin contracted to 4.3% from 5.47% in the prior year period, a decline of 117 basis points, indicating pricing pressure or unfavorable product mix. Gross margin decreased 29 basis points to 14.9% while selling, general and administrative expenses rose to 10.65% of sales from 9.76%, increasing 89 basis points as fixed costs were absorbed over a smaller revenue base. Ordinary margin declined 79 basis points to 4.11% from 4.90%, though foreign exchange losses narrowed to 0.26B yen from 0.83B yen and interest expense remained contained at 0.16B yen. Net profit margin of 3.43% was nearly flat year-over-year at -1 basis point, supported by the 1.1B yen investment securities gain which contributed approximately 0.7B yen post-tax. [Cash Quality] Cash and deposits stood at 5.6B yen with short-term debt coverage of 0.97 times, indicating balanced near-term liquidity. Operating cash flow of 8.9B yen represented 1.77 times net income, demonstrating strong cash conversion. Free cash flow reached 9.7B yen with operating activities generating sufficient funds to cover capital expenditures and provide surplus for shareholder returns. [Investment Efficiency] Total asset turnover of 0.927 declined from higher prior levels as sales contracted 9.5% while asset base remained elevated. Days sales outstanding extended to approximately 135 days, days inventory outstanding reached approximately 135 days, and cash conversion cycle lengthened to approximately 208 days, reflecting deterioration in working capital velocity. [Financial Health] Equity ratio of 31.6% with current ratio of 173.1% and quick ratio of 118.4% indicate adequate liquidity buffers. Debt-to-equity ratio of 0.42 for interest-bearing debt remains manageable with interest coverage ratio of 39.7 times providing substantial cushion. Total liabilities to equity of 2.16 times reflects higher operational leverage though delevering progressed with long-term borrowings declining 38.4% to 15.2B yen and short-term borrowings decreasing 29.0% to 5.8B yen.
Operating cash flow of 8.9B yen represents 1.77 times net income, confirming cash-backed earnings quality. The primary driver was advances received increasing 8.0B yen, reflecting customer prepayments on ongoing projects, while inventory reduction contributed 4.8B yen as the company worked down stock levels. Offsetting these inflows, trade receivables increased 4.3B yen, absorbing working capital. Investing cash flow generated a positive 0.8B yen, primarily from proceeds of 1.2B yen in investment securities sales and recovery of guarantee deposits, exceeding modest capital expenditures. Financing cash flow reflected debt reduction with long-term borrowings declining 9.5B yen and short-term borrowings decreasing 2.4B yen, while the company distributed 2.0B yen in share buybacks, demonstrating balanced capital allocation. Free cash flow of 9.7B yen provides a dividend coverage ratio of 2.60 times based on the planned annual dividend, indicating sustainable payout capacity. The substantial contribution from advances received warrants monitoring as project completion and delivery will reverse this working capital benefit in subsequent periods. Cash position decreased 2.7B yen to 5.6B yen, reflecting strategic debt repayment that reduced interest-bearing liabilities by 12.2B yen to 21.0B yen, improving the net debt position and reducing financial costs going forward.
Ordinary income of 6.0B yen compared to operating income of 6.3B yen indicates a net non-operating loss of approximately 0.3B yen. This comprises primarily foreign exchange losses of 0.26B yen, which improved from 0.83B yen in the prior year, and interest expenses of 0.16B yen, offset partially by equity method investment gains and financial income. Non-operating items represent approximately 0.2% of revenue on a net basis. Special profit included investment securities sales gains of 1.1B yen, which contributed an estimated 0.7B yen to net income after tax, representing approximately 13.8% of reported net income. Excluding this one-time gain, normalized net income would approximate 4.3B yen, indicating core earnings run at a lower trajectory than the reported figure. Operating cash flow exceeding net income at 1.77 times reflects healthy earnings quality from a cash realization perspective, though the composition reveals dependence on timing-sensitive items. The 8.0B yen increase in advances received, while boosting current period cash flow, represents customer prepayments that will reverse as projects are delivered, creating potential headwinds in future quarters. The 4.8B yen inventory reduction improved cash but extended inventory days to approximately 135, suggesting slower turnover rather than efficiency gains. Trade receivables absorption of 4.3B yen despite sales declining 9.5% indicates collection challenges or extended payment terms, with days sales outstanding similarly elevated. The reliance on working capital timing effects and a material one-time investment gain to support cash flow and reported earnings introduces elevated variance risk to normalized run-rate profitability and future cash generation.
Margin compression risk intensified with gross margin declining 29 basis points to 14.9% and operating margin contracting 117 basis points to 4.3%, suggesting pricing pressure or unfavorable product mix that may persist if demand conditions remain soft. The company's full-year guidance implies sales of 200B yen (down 7.6% year-over-year) and ordinary income of 9.1B yen (down 20.3%), indicating management anticipates continued headwinds. Working capital efficiency deterioration presents liquidity and profitability risks, with days sales outstanding and days inventory outstanding each extending to approximately 135 days and cash conversion cycle reaching approximately 208 days. The elevated receivables level despite declining sales and high inventory days raise potential for valuation adjustments or bad debt charges, while the 8.0B yen increase in advances received will reverse as projects complete, potentially creating cash flow volatility in Q4 and the subsequent fiscal year. Dependence on one-time gains distorts earnings quality, as the 1.1B yen investment securities gain contributed an estimated 0.7B yen or 13.8% of reported net income. Normalized core earnings excluding this item would approximate 4.3B yen, and the absence of similar gains in future periods combined with advances received reversing could compress both reported profitability and cash flow generation capacity, particularly if top-line recovery and margin improvement do not materialize in line with the Q4 budget.
[Industry Position] (Reference - Proprietary Analysis) The company's operating margin of 4.3% aligns with the trading industry median of 3.2% (Q3 2025, n=15), positioning above the 25th percentile of 1.3% but below the 75th percentile of 4.6%, indicating mid-tier profitability within the sector. Net profit margin of 3.4% exceeds the industry median of 2.0% (IQR: 1.0%-3.9%), ranking in the upper half despite year-over-year contraction. ROE of 10.0% significantly outperforms the industry median of 3.7% (IQR: 2.2%-8.4%), reflecting higher leverage and asset productivity relative to peers. The equity ratio of 31.6% falls below the industry median of 47.8% (IQR: 43.0%-55.5%), consistent with higher financial leverage of 3.16 versus the industry median of 1.97 (IQR: 1.80-2.33), indicating more aggressive capital structure. Current ratio of 1.73 sits below the industry median of 1.88 (IQR: 1.64-2.38) but remains within the interquartile range, suggesting adequate though not exceptional liquidity. Asset turnover of 0.927 underperforms the industry median of 1.06 (IQR: 0.70-1.32), highlighting asset productivity challenges. Working capital efficiency lags substantially, with inventory turnover at approximately 135 days vastly exceeding the industry median of 51 days (IQR: 31-75 days), and receivables turnover of approximately 135 days also above the median of 74 days (IQR: 65-91 days). Revenue growth of -9.5% underperforms the industry median of +2.6% (IQR: -5.3% to +10.8%), placing the company in the bottom quartile for top-line momentum. The company's financial leverage and profitability ratios position it favorably on return metrics, but working capital management and revenue trajectory lag peers, indicating room for operational improvement to align with industry norms. ※ Industry: Trading (15 companies), Comparison: Q3 2025 period, Source: Proprietary analysis
Margin erosion amid revenue contraction signals cyclical or competitive challenges requiring operational response. Operating margin compressed 117 basis points to 4.3% while revenue declined 9.5%, with gross margin narrowing 29 basis points and SG&A expense ratios rising 89 basis points, indicating negative operating leverage. The full-year guidance of 9.1B yen ordinary income (down 20.3%) and 200B yen sales (down 7.6%) suggests management does not anticipate near-term recovery, placing focus on Q4 execution and early signs of stabilization in pricing, mix, or volume trends. Segment visibility is limited to Computer System sales of 29.4B yen and Semiconductor and Electronic Device sales of 117.3B yen, together representing only 146.7B yen of cumulative quarterly sales, leaving the contribution and trajectory of other business lines unclear. Cash generation remains a relative strength despite profit pressure, with operating cash flow of 8.9B yen at 1.77 times net income and free cash flow of 9.7B yen supporting a dividend payout ratio of 74.1% and 2.60 times free cash flow coverage. The 2.0B yen share buyback demonstrates commitment to shareholder returns even as core profitability weakens. However, operating cash flow quality is heavily influenced by advances received increasing 8.0B yen, a timing benefit that will reverse upon project delivery, and inventory reduction of 4.8B yen occurring alongside deteriorating turnover metrics (approximately 135 days inventory outstanding versus industry median of 51 days). Working capital normalization in subsequent periods could reduce cash flow materially unless offset by margin recovery or sales acceleration. Deleveraging progress and financial resilience provide downside protection, with interest-bearing debt declining 12.2B yen to 21.0B yen, interest coverage maintaining 39.7 times, and debt-to-equity ratio of 0.42 remaining manageable. The equity ratio of 31.6% is below the industry median of 47.8%, but current and quick ratios of 173% and 118% respectively provide near-term liquidity buffers. Key forward indicators center on whether Q4 and FY2027 guidance show margin stabilization, working capital velocity improvement (particularly inventory and receivables turnover normalization), and sustainable cash flow absent the one-time benefit of advances received. The company's ability to execute on cost discipline, high-value product mix shift, and receivables management will determine whether profitability can return to mid-single-digit operating margins and ROE sustain above 10% without reliance on financial engineering or one-time gains.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.